146 related articles for article (PubMed ID: 8007712)
1. The introduction of activated oncogenes to mammary cells in vivo using retroviral vectors: a new model for the chemoprevention of premalignant and malignant lesions of the breast.
Gould MN
J Cell Biochem Suppl; 1993; 17G():66-72. PubMed ID: 8007712
[TBL] [Abstract][Full Text] [Related]
2. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
[TBL] [Abstract][Full Text] [Related]
3. Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.
Woditschka S; Haag JD; Waller JL; Monson DM; Hitt AA; Brose HL; Hu R; Zheng Y; Watson PA; Kim K; Lindstrom MJ; Mau B; Steele VE; Lubet RA; Gould MN
Cancer Res; 2006 Jul; 66(13):6884-91. PubMed ID: 16818667
[TBL] [Abstract][Full Text] [Related]
4. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
Bradbury JM; Arno J; Edwards PA
Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220
[TBL] [Abstract][Full Text] [Related]
5. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
[TBL] [Abstract][Full Text] [Related]
7. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas.
Stoesz SP; Gould MN
Oncogene; 1995 Dec; 11(11):2233-41. PubMed ID: 8570173
[TBL] [Abstract][Full Text] [Related]
9. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
10. Oncogenes, breast cancer, and chemoprevention.
Liu ET
J Cell Biochem Suppl; 1993; 17G():161-6. PubMed ID: 8007694
[TBL] [Abstract][Full Text] [Related]
11. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Green A; Shilkaitis A; Christov K
Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
[TBL] [Abstract][Full Text] [Related]
12. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
Morrison BW; Leder P
Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
[TBL] [Abstract][Full Text] [Related]
13. The genetic penetrance of the activated neu oncogene for the induction of mammary cancer in vivo.
Tai YT; Gould MN
Oncogene; 1997 Jun; 14(22):2701-7. PubMed ID: 9178768
[TBL] [Abstract][Full Text] [Related]
14. Biological and molecular characteristics of the premalignant mouse mammary gland.
Medina D
Biochim Biophys Acta; 2002 Oct; 1603(1):1-9. PubMed ID: 12242106
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
16. Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas.
McFarlin DR; Lindstrom MJ; Gould MN
Carcinogenesis; 2003 Jan; 24(1):99-105. PubMed ID: 12538354
[TBL] [Abstract][Full Text] [Related]
17. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E
Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
[TBL] [Abstract][Full Text] [Related]
19. A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.
Woditschka S; Haag JD; Sullivan R; Gould MN
Cancer Prev Res (Phila); 2009 Feb; 2(2):153-60. PubMed ID: 19196722
[TBL] [Abstract][Full Text] [Related]
20. Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.
Muller WJ
Cancer Metastasis Rev; 1991 Oct; 10(3):217-27. PubMed ID: 1662559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
